165 related articles for article (PubMed ID: 2578172)
1. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.
Berman B; Duncan MR; Smith B; Ziboh VA; Palladino M
J Invest Dermatol; 1985 Jan; 84(1):54-8. PubMed ID: 2578172
[TBL] [Abstract][Full Text] [Related]
2. Modulation of class II (DR and DQ) antigen expression on gingival Langerhans cells in vitro by gamma interferon and prostaglandin E2.
Walsh LJ; Seymour GJ; Powell RN
J Oral Pathol; 1986 Jul; 15(6):347-51. PubMed ID: 3093653
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
4. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
[TBL] [Abstract][Full Text] [Related]
5. Modulation of CD4 antigen expression on human gingival Langerhans cells by gamma interferon.
Walsh LJ; Parry A; Scholes A; Seymour GJ
Clin Exp Immunol; 1987 Nov; 70(2):379-85. PubMed ID: 3123106
[TBL] [Abstract][Full Text] [Related]
6. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
[TBL] [Abstract][Full Text] [Related]
8. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
Kelley VE; Fiers W; Strom TB
J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
[TBL] [Abstract][Full Text] [Related]
9. Regulation of expression of class II major histocompatibility antigens on human peripheral blood monocytes and Langerhans cells by interferon.
Basham T; Smith W; Lanier L; Morhenn V; Merigan T
Hum Immunol; 1984 Jun; 10(2):83-93. PubMed ID: 6203882
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
11. Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured normal human keratinocytes.
Basham TY; Nickoloff BJ; Merigan TC; Morhenn VB
J Interferon Res; 1985; 5(1):23-32. PubMed ID: 3921630
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.
Sztein MB; Steeg PS; Johnson HM; Oppenheim JJ
J Clin Invest; 1984 Feb; 73(2):556-65. PubMed ID: 6230374
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
Masuyama J; Minato N; Kano S
J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
Ashworth J; Kahan MC; Breathnach SM
J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
[TBL] [Abstract][Full Text] [Related]
16. Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes.
Auböck J; Niederwieser D; Romani N; Fritsch P; Huber C
Arch Dermatol Res; 1985; 277(4):270-5. PubMed ID: 3923947
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma induces HLA-DR expression by thyroid epithelium.
Todd I; Pujol-Borrell R; Hammond LJ; Bottazzo GF; Feldmann M
Clin Exp Immunol; 1985 Aug; 61(2):265-73. PubMed ID: 3930110
[TBL] [Abstract][Full Text] [Related]
18. Human keratinocyte-lymphocyte reactions in vitro.
Nickoloff BJ; Basham TY; Merigan TC; Torseth JW; Morhenn VB
J Invest Dermatol; 1986 Jul; 87(1):11-8. PubMed ID: 2941488
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes.
Nickoloff BJ; Basham TY; Merigan TC; Morhenn VB
Lab Invest; 1984 Dec; 51(6):697-701. PubMed ID: 6209471
[TBL] [Abstract][Full Text] [Related]
20. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
